Genoptix Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genoptix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7338
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. Genoptix’s biopharma services include clinical trial testing, custom assay development, and companion diagnostic services. Genoptix also offers patient assessment services for colorectal, breast, lung, blood, melanoma and skin care; and general disease applications. The center provides its clinical oncology diagnostic services, personalized and comprehensive solutions to community-based hematologists, oncologists and pathologists in the US. Genoptix is headquartered in Carlsbad, California, the US.

Genoptix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genoptix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genoptix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genoptix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genoptix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genoptix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genoptix Inc, Medical Equipment, Deal Details 10
Partnerships 10
MolecularMD and Genoptix Enter into Agreement 10
Genoptix Enters into Distribution Agreement with Rosetta Genomics 11
Genoptix and Bionano Genomics Enter into Co-Development Agreement 12
Acquisition 13
Genoptix to Acquire Rosetta Genomics for USD9 Million 13
Genoptix Inc – Key Competitors 15
Genoptix Inc – Key Employees 16
Genoptix Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Genoptix Inc, Medical Equipment, Key Facts 2
Genoptix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genoptix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genoptix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genoptix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genoptix Inc, Deals By Market, 2012 to YTD 2018 8
Genoptix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MolecularMD and Genoptix Enter into Agreement 10
Genoptix Enters into Distribution Agreement with Rosetta Genomics 11
Genoptix and Bionano Genomics Enter into Co-Development Agreement 12
Genoptix to Acquire Rosetta Genomics for USD9 Million 13
Genoptix Inc, Key Competitors 15
Genoptix Inc, Key Employees 16
Genoptix Inc, Other Locations 17

List of Figures
Genoptix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genoptix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genoptix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genoptix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genoptix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genoptix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genoptix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genoptix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genoptix Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wellcome Trust Sanger Institute-医療機器分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Transcontinental Inc (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Applebee’s Restaurants LLC:企業の戦略・SWOT・財務情報
    Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report Summary Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Facebook, Inc.:企業のM&A・事業提携・投資動向
    Facebook, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Facebook, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務情報
    Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Optum Inc-医療機器分野:企業M&A・提携分析
    Summary Optum Inc (Optum), a subsidiary of UnitedHealth Group Inc is a healthcare service provider that offers health IT, pharmacy care services, population health management, data and analytics, financial services, health care delivery, revenue cycle management, and health plan operations. The comp …
  • Marine Harvest ASA:企業のM&A・事業提携・投資動向
    Marine Harvest ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marine Harvest ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Astute Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Siemens Healthcare GmbH-医療機器分野:企業M&A・提携分析
    Summary Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure …
  • Diebold Nixdorf, Incorporated:戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ABPA Holdings Limited:企業の戦略的SWOT分析
    ABPA Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • Triskalia SCA:企業の戦略・SWOT・財務情報
    Triskalia SCA - Strategy, SWOT and Corporate Finance Report Summary Triskalia SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Miltenyi Biotec GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company's services include sample preparation, cell separation, flow cytometry, cell cultur …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Rubicon Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • Peako Ltd (PKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is an oil and gas, and mineral exploration company. The company carries out the business of acquisition, exploration, and development of oil, natural gas, petroleum, and uranium properties. Its projects include SC6C Cadlao and Sunday Creek proj …
  • Stealth BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Stealth BioTherapeutics Inc (Stealth), formerly Stealth Peptides Inc is a clinical stage biopharmaceutical company that develops therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. The company offers elamipretide, a mitoch …
  • Singulex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆